Necitumumab: a new therapeutic option for squamous cell lung cancer?

Por Pillai, Rathi N., Ramalingam, Suresh S.
Publicado no Transl Lung Cancer Res (2014)

Inhibition of insulin-like growth factor receptor: end of a targeted therapy?

Por Pillai, Rathi N., Ramalingam, Suresh S.
Publicado no Transl Lung Cancer Res (2013)

Small Cell Lung Cancer: Therapies and Targets

Por Pillai, Rathi N, Owonikoko, Taofeek K
Publicado em 2013

Multicentric Castleman’s disease in HIV/AIDS patients at an urban HIV clinic in Atlanta, Georgia, in the combined antiretroviral therapy era

Por Pillai, Rathi N, Gunthel, Clifford, Adamski, Marylyn, Mosunjac, Marina, Ly Nguyen, Minh
Publicado em 2012

OP14 METASTASIS INDUCING PROTEINS PREDICT THE INVASIVENESS AND CLINICAL OUTCOMES OF BRAIN METASTASES

Por Zakaria, R., Rathi, N., Crooks, D., Brodbelt, A., Rudland, P.R., Jenkinson, M.D.
Publicado em 2014

Effect of Ocimum sanctum, ascorbic acid, and verapamil on macrophage function and oxidative stress in mice exposed to cocaine

Por Bhattacharya, S.K., Rathi, N., Mahajan, P., Tripathi, A.K., Paudel, K.R., Rauniar, G.P., Das, B.P.
Publicado em 2009

Interferon Alpha Plus 13-Cis-Retinoic Acid Modulation of BCL-2 Plus Paclitaxel for Recurrent Small Cell Lung Cancer (SCLC): An Eastern Cooperative Oncology Group Study (E6501)

Por Pillai, Rathi N., Aisner, Joseph, Dahlberg, Suzanne E., Rogers, John S., DiPaola, Robert S., Aisner, Seena, Ramalingam, Suresh S., Schiller, Joan H.
Publicado no Cancer Chemother Pharmacol (2014)

OS4.1 A risk calculator to predict the need for an intervention within a patient’s estimated lifetime for incidentally-found asymptomatic meningiomas

Por Islim, A I, Mohan, M, Moon, R, Kolamunnage-Dona, R, Rathi, N, Mills, S J, Brodbelt, A R, Jenkinson, M D
Publicado no Neuro Oncol (2018)

Multifaceted actions of 8-amino-adenosine kill BCR-ABL positive cells

Por Pillai, Rathi N., Chen, Lisa S., Ayres, Mary L., Nowak, Billie J., Thomas, Michael W., Shpall, Elizabeth J., Keating, Michael J., Gandhi, Varsha
Publicado no Leuk Lymphoma (2012)

HER2 Mutations in Lung Adenocarcinomas: A Report from the Lung Cancer Mutation Consortium

Por Pillai, Rathi N., Behera, Madhusmita, Berry, Lynne D., Rossi, Mike R., Kris, Mark G., Johnson, Bruce E., Bunn, Paul A., Ramalingam, Suresh S., Khuri, Fadlo R.
Publicado no Cancer (2017)

Trends, predictors and impact of systemic chemotherapy in small cell lung cancer patients between 1985 and 2005

Por Behera, Madhusmita, Ragin, Camille, Kim, Sungjin, Pillai, Rathi N., Chen, Zhengjia, Steuer, Conor E., Saba, Nabil F., Belani, Chandra P., Khuri, Fadlo R., Ramalingam, Suresh S., Owonikoko, Taofeek K.
Publicado no Cancer (2015)

Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report

Por Owonikoko, Taofeek K., Kumar, Mukesh, Yang, Shu, Kamphorst, Alice O., Pillai, Rathi N., Akondy, Rama, Nautiyal, Vivek, Chatwal, Monica S., Book, Wendy M., Sahu, Anurag, Sica, Gabriel L., Ahmed, Rafi, Ramalingam, Suresh S.
Publicado no Cancer Immunol Immunother (2016)

Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis

Por Tian, Sibo, Switchenko, Jeffrey M., Buchwald, Zachary S., Patel, Pretesh R., Shelton, Joseph W., Kahn, Shannon E., Pillai, Rathi N., Steuer, Conor E., Owonikoko, Taofeek K., Behera, Madhusmita, Curran, Walter J., Higgins, Kristin A.
Publicado no Int J Radiat Oncol Biol Phys (2020)

Stereotactic Body Radiotherapy for Early-stage Non–small-cell Lung Cancer in Patients 80 Years and Older: A Multi-center Analysis

Por Cassidy, Richard J., Patel, Pretesh R., Zhang, Xinyan, Press, Robert H., Switchenko, Jeffrey M., Pillai, Rathi N., Owonikoko, Taofeek K., Ramalingam, Suresh S., Fernandez, Felix G., Force, Seth D., Curran, Walter J., Higgins, Kristin A.
Publicado no Clin Lung Cancer (2017)

Trimodality Therapy in the Treatment of Stage III N2‐Positive Non‐Small Cell Lung Cancer: A National Cancer Database Analysis

Por Behera, Madhusmita, Steuer, Conor E., Liu, Yuan, Fernandez, Felix, Fu, Chao, Higgins, Kristin A., Gillespie, Theresa W., Pakkala, Suchita, Pillai, Rathi N., Force, Seth, Belani, Chandra P., Khuri, Fadlo R., Curran, Walter J., Ramalingam, Suresh S.
Publicado no Oncologist (2020)

Post-Operative Radiotherapy (PORT) is Associated with Better Survival in Non-Small Cell Lung Cancer with Involved N2 Lymph Nodes: Results of an Analysis of the National Cancer Data...

Por Mikell, John L., Gillespie, Theresa W., Hall, William A., Nickleach, Dana C., Liu, Yuan, Lipscomb, Joseph, Ramalingam, Suresh S., Rajpara, Raj S., Force, Seth D., Fernandez, Felix G., Owonikoko, Taofeek K., Pillai, Rathi N., Khuri, Fadlo R., Curran, Walter J., Higgins, Kristin A.
Publicado no J Thorac Oncol (2015)

CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC

Por Pillai, Rathi N, Brodie, Seth A, Sica, Gabriel L, Shaojin, You, Li, Ge, Nickleach, Dana C, Yuan, Liu, Varma, Vijay A, Bonta, Dacian, Herman, James G, Brock, Malcom V, Ribeiro, Maria JA, Ramalingam, Suresh S, Owonikoko, Taofeek K, Khuri, Fadlo R, Brandes, Johann C
Publicado em 2013

Nivolumab monotherapy in recurrent metastatic urothelial carcinoma (CheckMate 032): a multicentre, open-label, phase 1/2 trial

Por Sharma, Padmanee, Callahan, Margaret K, Bono, Petri, Kim, Joseph, Spiliopoulou, Pavlina, Calvo, Emiliano, Pillai, Rathi N, Ott, Patrick A, de Braud, Filippo, Morse, Michael, Le, Dung T, Jaeger, Dirk, Chan, Emily, Harbison, Chris, Lin, Chen-Sheng, Tschaika, Marina, Azrilevich, Alex, Rosenberg, Jonathan E
Publicado no Lancet Oncol (2016)

Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1–targeted therapy in lung cancer patients

Por Kamphorst, Alice O., Pillai, Rathi N., Yang, Shu, Nasti, Tahseen H., Akondy, Rama S., Wieland, Andreas, Sica, Gabriel L., Yu, Ke, Koenig, Lydia, Patel, Nikita T., Behera, Madhusmita, Wu, Hong, McCausland, Megan, Chen, Zhengjia, Zhang, Chao, Khuri, Fadlo R., Owonikoko, Taofeek K., Ahmed, Rafi, Ramalingam, Suresh S.
Publicado no Proc Natl Acad Sci U S A (2017)

Healthcare disparities among octogenarians and nonagenarians with stage III lung cancer

Por Cassidy, Richard J., Zhang, Xinyan, Switchenko, Jeffrey M., Patel, Pretesh R., Shelton, Joseph W., Tian, Sibo, Nanda, Ronica H., Steuer, Conor E., Pillai, Rathi N., Owonikoko, Taofeek K., Ramalingam, Suresh S., Fernandez, Felix G., Force, Seth D., Gillespie, Theresa W., Curran, Walter J., Higgins, Kristin A.
Publicado no Cancer (2018)